Human Stem Cells Institute PJSC reported unaudited consolidated earnings results for the first quarter ended March 31, 2017. For the quarter, total revenue was RUB 115,007,000 against RUB 93,644,000 a year ago. OIBDA loss was RUB 26,801,000 against OIBDA income of RUB 10,426,000 a year ago. Operating loss was RUB 36,665,000 against income of RUB 3,878,000 a year ago. Loss before income tax was RUB 29,216,000 against RUB 8,272,000 a year ago. Total comprehensive loss was RUB 29,498,000 against RUB 7,267,000 a year ago.